UNI-EN 44:A transaction concluded by the subsidiary "Pharmalogistika" AD under Art. 114, para. 3 of the Law on Public Offering of Securities requiring prior approval of the public company
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 44 | / | 2023 | |||||||
| Date of issue: | 2023-06-09 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| A transaction concluded by the subsidiary "Pharmalogistika" AD under Art. 114, para. 3 of the Law on Public Offering of Securities requiring prior approval of the public company | |||||||||||
| Official market - legal basis | |||||||||||
| art. 56. 1. 2 of Act on Public Offering. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| “Sopharma” AD (the Company) hereby informs that following a request made to the parent company "Sopharma" AD by the subsidiary "Pharmalogistika" AD and the consent given by the Board of Directors on 06.06.2023, today the subsidiary concluded the following transaction falling within the scope of Art. 114 para. 3 of the Securities Act: | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| SFA_09062023_Phramalogistica_114_espi.pdf SFA_09062023_Phramalogistica_114_espi.pdf | A transaction concluded by the subsidiary "Pharmalogistika" AD under Art. 114, para. 3 of the Law on Public Offering of Securities requiring prior approval of the public company | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2023-06-09 | Ognian Donev | Executive Director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 16.0 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
